Resultados de la búsqueda 221-230 of 15514 for palliative care
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?
The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...
A Study to Evaluate sPD-L1 Clearance in Patients Undergoing Plasma Exchange Therapy. Rochester, Minn. The purpose of this study is to establish the clearance ...
Page 1.
The purpose of this study is to evaouate how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) ...
The aim of this study is to better identify trends in trainee remediation and outcome in a large quaternary care academic institution, in an effort to improve ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.